Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.
Fu-Shun YenChii-Min HwaJia-Sin LiuYi-Ling WuKeong ChongChih-Cheng HsuPublished in: Annals of internal medicine (2024)
National Health Research Institutes, Taiwan.